Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

American College of Radiology (ACR) Chief Executive Officer Dana Smetherman, MD, explains the highlights of the recent BI-RADS Version 2025 release, which is the first update to BI-RADS in about a decade. #ACR #RSNA #BIRADS

ACR outlines key changes in the new BI-RADS guidelines

American College of Radiology Chief Executive Officer Dana Smetherman, MD, explains the highlights of the recent BI-RADS Version 2025 release, the first update in more than a decade.
 

merger acquisition M&A business

Haemonetics acquires Irish medtech company focused on vessel closure for up to $215M

The device at the heart of this transaction is the PerQseal Elite system, a fully bioabsorbable patch for percutaneous vessel closure. The technology has already gained key approvals in Europe. 

Mirvat Alasnag, MD, FACP, FACC, FSCAI, FSCCT, director of catheterization laboratory and research, King Fahd Armed Forces Hospital, Jeddah-Saudi Arabia, Ditrector of TCT Middle East, and member of Society of Cardiovascular CT (SCCT) Education Committee, explains how the society it translating its educational content into other languages to help a wider international audience of clinicians. SCCT is working to expand its international membership and this is a big part of that strategy.

SCCT expands CCTA education overseas

SCCT has made it a priority to help clinicians from all over the world learn more about CCTA as the modality continues to transform patient care. 

PET-CT imaging of 124-I evuzamitide and SPECT-CT imaging of 99mTc-p5+14 showed radiotracer uptake in both AL and ATTR amyloid throughout the myocardium. Emily B. Martin, Anne Kassira, Alan Stuckey, et al. A tale of two tracers - Amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05). https://www.journalofnuclearcardiology.org/article/S1071-3581(25)00325-3/abstract.

Bayer expands into molecular imaging with cardiac amyloidosis tracer acquisitions

Bayer is acquiring two cardiac amyloidosis radiotracers from Attralus, one for PET and one for SPECT. The SPECT tracer is also a theranostic agent to both image and treat amyloidosis.

Medicare money payment

Imaging providers must act to preserve higher CT pay, American College of Radiology warns

CMS previously announced it was temporarily reassigning payment codes for coronary CT angiography, resulting in a 104% higher technical fee. 

Bayer

Bayer expands into molecular imaging with 2 acquisitions

The company has reached a deal to purchase two investigational imaging agents from Attralus Inc., a Naples, Florida-based biopharmaceutical firm.

istock-1359148358.jpg

MRI technique reduces low-value surgeries for patients with colorectal cancer

Though effective, surgery for colorectal peritoneal metastases is accompanied by a high risk of major morbidity, making the decision to undergo the procedure complex for many patients.  

Thumbnail

TAVR, other interventional procedures may provide value for patients with carcinoid heart disease

These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.